Practice
Featured experience
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Durational Capital Management strategic investment in Garage Beer
We are advising Durational Capital Management on the transaction
Arcos Dorados renewal of long-term master franchise agreement with McDonald’s
We advised Arcos Dorados on the transaction
GSK strategic alliance with Vesalius Therapeutics
We advised GSK on the transaction
Eikon Therapeutics $381 million IPO
We advised the representatives of the several underwriters on the IPO
Lightyear Capital acquisition of PayByPhone
We are advising Lightyear Capital on the transaction
York Space Systems $629 million IPO
We are advising the representatives of the underwriters on the IPO
EquipmentShare $860 million IPO
We advised EquipmentShare on its IPO
CoreWeave $2 billion equity raise and collaboration framework with NVIDIA
We advised CoreWeave on the transaction
Leidos $2.4 billion acquisition of ENTRUST Solutions Group
We are advising Leidos on the transaction
AbelZeta sale of China rights to GPC3 CAR-T therapy to AstraZeneca
We advised AbelZeta on the transaction
Delinea acquisition of StrongDM
We are advising TPG and Delinea on the transaction
Penumbra $14.5 billion sale to Boston Scientific
We are advising Penumbra on the transaction
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026